User profiles for J. Riba

Jordi Riba

- Verified email at maastrichtuniversity.nl - Cited by 10605

Jordi-Roger Riba Ruiz

- Verified email at ee.upc.edu - Cited by 6332

Josep Ferrer Riba

- Verified email at upf.edu - Cited by 1227

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …

…, FL Osório, JAS Crippa, J Riba… - Therapeutic …, 2016 - journals.sagepub.com
To date, pharmacological treatments for mood and anxiety disorders and for drug dependence
show limited efficacy, leaving a large number of patients suffering severe and persistent …

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

…, P Friedlander, A Feilding, J Riba - Brain research …, 2016 - Elsevier
Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and
used for ritual purposes by the indigenous populations of the Amazon. The use of a variation …

Rare-earth-free propulsion motors for electric vehicles: A technology review

JR Riba, C López-Torres, L Romeral… - … and Sustainable Energy …, 2016 - Elsevier
Several factors including fossil fuels scarcity, prices volatility, greenhouse gas emissions or
current pollution levels in metropolitan areas are forcing the development of greener …

CuO, ZrO2 and ZnO nanoparticles as antiwear additive in oil lubricants

…, JMD Fernández, A Machado, R Chou, J Riba - Wear, 2008 - Elsevier
This work presents and discusses the antiwear behaviour of nanoparticle suspensions in a
polyalphaolefin (PAO 6). CuO, ZnO and ZrO 2 nanoparticles were separately dispersed at 0.5…

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

…, G de Oliveira Silveira, M Yonamine, J Riba… - Psychological …, 2019 - cambridge.org
BackgroundRecent open-label trials show that psychedelics, such as ayahuasca, hold
promise as fast-onset antidepressants in treatment-resistant depression.MethodsTo test the …

[HTML][HTML] Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

…, L Wichert-Ana, DB De Araujo, J Riba… - Brazilian Journal of …, 2015 - SciELO Brasil
J Ethnopharmacol. 2007;112:507-13., 39 39. Riba J, Barbanoj MJ. Bringing ayahuasca
to the clinical … Riba J, Barbanoj MJ. Bringing ayahuasca to the clinical research laboratory. …

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study

…, L Wichert-Ana, DB de Araujo, J Riba… - Journal of clinical …, 2016 - journals.lww.com
Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine,
a 5-HT 2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group …

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

J Riba, M Valle, G Urbano, M Yritia, A Morte… - … of Pharmacology and …, 2003 - ASPET
The effects of the South American psychotropic beverage ayahuasca on subjective and
cardiovascular variables and urine monoamine metabolite excretion were evaluated, together …

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

J Riba, A Rodríguez-Fornells, G Urbano, A Morte… - …, 2001 - Springer
Rationale: Ayahuasca is a South American psychoactive beverage that contains the naturally
occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for …

[HTML][HTML] Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study

…, WS Araújo, MJ Barbanoj, JM Fábregas, J Riba - 2012 - journals.plos.org
Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT
2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (…